Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin injection for internal anal sphincter achalasia
2005-002335-27Phase 3Active
- Sponsor
- Istituto Giannina Gaslini
- Start
- Jun 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of neuronox in Internal anal sphincter achalasia (IASA), sponsored by Istituto Giannina Gaslini. Started Jun 2005; status: active.
02
Drugs
neuronox
03
Conditions
Internal anal sphincter achalasia (IASA)
Beyond the preview
Go deeper on 2005-002335-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002335-27.